• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺结节病中血管紧张素转换酶的诊断意义

Diagnostic aspects of angiotensin converting enzyme in pulmonary sarcoidosis.

作者信息

Bunting P S, Szalai J P, Katic M

机构信息

Department of Biochemistry, Sunnybrook Medical Centre, University of Toronto, Ontario.

出版信息

Clin Biochem. 1987 Jun;20(3):213-9. doi: 10.1016/s0009-9120(87)80123-6.

DOI:10.1016/s0009-9120(87)80123-6
PMID:2820616
Abstract

Angiotensin converting enzyme (ACE) has been measured in 102 biopsy-proven sarcoid patients, 70 patients diagnosed by clinical and radiological methods and 74 nonsarcoid patients as controls. The distributions of the various groups have been examined, and the effects of stage of disease, disease activity and prednisone treatment have been evaluated. Receiver operating characteristic (ROC) curves have been established for ACE, and the appropriateness of various statistical procedures is discussed. We have not discerned any effect of stage of sarcoidosis or of extent of disease activity on ACE values. The ROC curves suggest an upper limit of normal of about 50 U/L for our assay, and a sensitivity of 63% and specificity of 93%, yielding predictive values of 93% for a positive result and 74% for a negative result, with a likelihood ratio of 3.6. The results are discussed in the context of other work on ACE and in relation to the more invasive procedures of bronchoalveolar lavage and Gallium scan.

摘要

对102例经活检证实的结节病患者、70例通过临床和放射学方法诊断的患者以及74例非结节病患者作为对照测定了血管紧张素转换酶(ACE)。检查了各组的分布情况,并评估了疾病分期、疾病活动度和泼尼松治疗的影响。建立了ACE的受试者工作特征(ROC)曲线,并讨论了各种统计程序的适用性。我们没有发现结节病分期或疾病活动程度对ACE值有任何影响。ROC曲线表明,我们的检测方法正常上限约为50 U/L,敏感性为63%,特异性为93%,阳性结果预测值为93%,阴性结果预测值为74%,似然比为3.6。将结合其他关于ACE的研究以及与支气管肺泡灌洗和镓扫描等侵入性更强的检查方法的相关性来讨论这些结果。

相似文献

1
Diagnostic aspects of angiotensin converting enzyme in pulmonary sarcoidosis.肺结节病中血管紧张素转换酶的诊断意义
Clin Biochem. 1987 Jun;20(3):213-9. doi: 10.1016/s0009-9120(87)80123-6.
2
Does serum angiotensin converting enzyme reflect intensity of alveolitis in sarcoidosis?血清血管紧张素转换酶能否反映结节病中肺泡炎的严重程度?
Thorax. 1985 Jul;40(7):497-500. doi: 10.1136/thx.40.7.497.
3
Lung inflammation in sarcoidosis: comparison of serum angiotensin-converting enzyme levels with bronchoalveolar lavage and gallium-67 scanning assessment of the T lymphocyte alveolitis.结节病中的肺部炎症:血清血管紧张素转换酶水平与支气管肺泡灌洗及镓-67扫描评估T淋巴细胞肺泡炎的比较
Thorax. 1982 Jan;37(1):19-25. doi: 10.1136/thx.37.1.19.
4
Predictive value of gallium scan, angiotensin-converting enzyme level, and bronchoalveolar lavage in two-year follow-up of pulmonary sarcoidosis.
Lung. 1987;165(6):371-7. doi: 10.1007/BF02714452.
5
Angiotensin-I-converting enzyme and gallium scan in noninvasive evaluation of sarcoidosis.血管紧张素转换酶及镓扫描在结节病无创评估中的应用
Ann Intern Med. 1979 Mar;90(3):328-31. doi: 10.7326/0003-4819-90-3-328.
6
The value of combined serum angiotensin-converting enzyme and gallium scan in diagnosing ocular sarcoidosis.联合血清血管紧张素转换酶与镓扫描在诊断眼部结节病中的价值。
Ophthalmology. 1995 Dec;102(12):2007-11. doi: 10.1016/s0161-6420(95)30763-4.
7
Angiotensin-converting enzyme in serum and in bronchoalveolar lavage in sarcoidosis.
Respiration. 1982;43(3):153-7. doi: 10.1159/000194479.
8
Diagnostic value of serum angiotensin converting enzyme activity in lung diseases.血清血管紧张素转换酶活性在肺部疾病中的诊断价值
Thorax. 1976 Oct;31(5):552-7. doi: 10.1136/thx.31.5.552.
9
Effects of sarcoid and steroids on angiotensin-converting enzyme.
Am Rev Respir Dis. 1983 Oct;128(4):631-3. doi: 10.1164/arrd.1983.128.4.631.
10
Gallium-67 in the evaluation of sarcoidosis: correlations with serum angiotensin-converting enzyme and bronchoalveolar lavage.镓-67在结节病评估中的应用:与血清血管紧张素转换酶及支气管肺泡灌洗的相关性
Thorax. 1982 Jan;37(1):11-8. doi: 10.1136/thx.37.1.11.

引用本文的文献

1
Diagnostic value of elevated serum angiotensin-converting enzyme and lymphopenia in patients with granulomatous hepatitis.血清血管紧张素转换酶升高及淋巴细胞减少在肉芽肿性肝炎患者中的诊断价值
Sarcoidosis Vasc Diffuse Lung Dis. 2023 Sep 13;40(3):e2023031. doi: 10.36141/svdld.v40i3.14221.
2
Performance of Serum Angiotensin-Converting Enzyme in Diagnosing Sarcoidosis and Predicting the Active Status of Sarcoidosis: A Meta-Analysis.血清血管紧张素转换酶在诊断结节病及预测结节病活动状态中的作用:一项荟萃分析。
Biomolecules. 2022 Sep 30;12(10):1400. doi: 10.3390/biom12101400.
3
Role of Neuron-Specific Enolase in the Diagnosis and Disease Monitoring of Sarcoidosis.
神经元特异性烯醇化酶在结节病诊断和疾病监测中的作用。
Can Respir J. 2022 May 26;2022:3726395. doi: 10.1155/2022/3726395. eCollection 2022.
4
Renal involvement in sarcoidosis: histological patterns and prognosis, an Italian survey.结节病的肾脏受累:组织学模式与预后,一项意大利的调查。
Sarcoidosis Vasc Diffuse Lung Dis. 2021;38(3):e2021017. doi: 10.36141/svdld.v38i3.11488. Epub 2021 Sep 30.
5
Primary hepatic sarcoidosis presenting with cholestatic liver disease and mimicking primary biliary cholangitis: a case report.以胆汁淤积性肝病为表现并酷似原发性胆汁性胆管炎的原发性肝结节病:一例报告
J Yeungnam Med Sci. 2022 Jul;39(3):256-261. doi: 10.12701/yujm.2021.01151. Epub 2021 Aug 10.
6
Sarcoidosis: Causes, Diagnosis, Clinical Features, and Treatments.结节病:病因、诊断、临床特征及治疗
J Clin Med. 2020 Apr 10;9(4):1081. doi: 10.3390/jcm9041081.
7
In Which Patients with Sarcoidosis Is FDG PET/CT Indicated?结节病患者中哪些适合进行氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG PET/CT)?
J Clin Med. 2020 Mar 24;9(3):890. doi: 10.3390/jcm9030890.
8
Hepatic Sarcoidosis: Natural History and Management Implications.肝结节病:自然史及管理意义
Front Med (Lausanne). 2019 Oct 30;6:232. doi: 10.3389/fmed.2019.00232. eCollection 2019.
9
Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis.血清可溶性白细胞介素-2 受体在疑似结节病患者人群中诊断结节病的敏感性和特异性。
PLoS One. 2019 Oct 17;14(10):e0223897. doi: 10.1371/journal.pone.0223897. eCollection 2019.
10
Clinical Manifestations, Diagnosis, and Treatment of Sarcoidosis.结节病的临床表现、诊断与治疗
Mayo Clin Proc Innov Qual Outcomes. 2019 Aug 2;3(3):358-375. doi: 10.1016/j.mayocpiqo.2019.04.006. eCollection 2019 Sep.